Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Raw Materials (2016 - 2025)

Standard Biotools (LAB) has disclosed Raw Materials for 15 consecutive years, with $12.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Raw Materials fell 75.04% to $12.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $12.5 million, a 75.04% decrease, with the full-year FY2024 number at $13.0 million, up 7.42% from a year prior.
  • Raw Materials was $12.5 million for Q3 2025 at Standard Biotools, up from $9.8 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $50.0 million in Q3 2024 to a low of $9.3 million in Q4 2021.
  • A 5-year average of $18.7 million and a median of $12.6 million in 2022 define the central range for Raw Materials.
  • Peak YoY movement for Raw Materials: surged 192.67% in 2024, then tumbled 80.09% in 2025.
  • Standard Biotools' Raw Materials stood at $9.3 million in 2021, then skyrocketed by 80.48% to $16.9 million in 2022, then fell by 28.02% to $12.1 million in 2023, then rose by 7.42% to $13.0 million in 2024, then decreased by 4.39% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Raw Materials are $12.5 million (Q3 2025), $9.8 million (Q2 2025), and $19.9 million (Q1 2025).